Interstitial Lung Disease Research Laboratory, Lawson Health Research Institute, London, ON, Canada.
London Health Sciences Research Institute, London, ON, Canada.
Sci Rep. 2024 Nov 2;14(1):26470. doi: 10.1038/s41598-024-77469-5.
Fibrosing interstitial lung diseases (ILDs) encompass a diverse range of scarring disorders that lead to progressive lung failure. Previous gene expression profiling studies focused on idiopathic pulmonary fibrosis (IPF) and bulk tissue samples. We employed digital spatial profiling to gain new insights into the spatial resolution of gene expression across distinct lung microenvironments (LMEs) in IPF, chronic hypersensitivity pneumonitis (CHP) and non-specific interstitial pneumonia (NSIP). We identified differentially expressed genes between LMEs within each condition, and across histologically similar regions between conditions. Uninvolved regions in IPF and CHP were distinct from normal controls, and displayed potential therapeutic targets. Hallmark LMEs of each condition retained distinct gene signatures, but these could not be reproduced in matched lung tissue samples. Based on these profiles and unsupervised clustering, we grouped previously unclassified ILD cases into NSIP or CHP. Overall, our work uniquely dissects gene expression profiles between LMEs within and across different types of fibrosing ILDs.
纤维性间质性肺疾病(ILDs)包括多种导致进行性肺衰竭的瘢痕性疾病。先前的基因表达谱研究集中在特发性肺纤维化(IPF)和组织样本上。我们采用数字空间分析方法,深入了解 IPF、慢性过敏性肺炎(CHP)和非特异性间质性肺炎(NSIP)等不同肺微环境(LMEs)中基因表达的空间分辨率。我们确定了每个条件下 LMEs 之间以及条件之间组织学相似区域之间差异表达的基因。IPF 和 CHP 中的未受累区域与正常对照不同,显示出潜在的治疗靶点。每个条件的标志性 LMEs 保留了独特的基因特征,但这些特征无法在匹配的肺组织样本中重现。基于这些图谱和无监督聚类,我们将以前未分类的ILD 病例分为 NSIP 或 CHP。总的来说,我们的工作独特地剖析了不同类型纤维性ILDs 内和之间的 LMEs 之间的基因表达谱。